http://www.legislation.gov.uk/uksi/2019/744/regulation/22/made
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
en
King's Printer of Acts of Parliament
2019-05-07
EXITING THE EUROPEAN UNION
MEDICINES
These Regulations are made in exercise of the powers conferred by section 8(1) of the European Union (Withdrawal) Act 2018 (c. 16) and amend the Medicines for Human Use (Clinical Trials) Regulations 2004 in order to address failures of retained EU law to operate effectively and other deficiencies (in particular under section 8(2)(a), (b), (c), (d), (f) and (g) and (6)) arising from the withdrawal of the United Kingdom from the European Union.
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
Amendment of regulation 56 (transitional provisions)22
In regulation 56, for “Schedule 12” substitute “Schedules 12 and 13”.